Table 4.
Serum prostaglandin E2, junction plakoglobin, glycosaminoglycan, and nitric oxide concentrations of healthy adult dogs supplemented one of three treatment oilsa on weeks 0, 2, 4, 10, and 16 of a skin and coat health trial, presented as lsmeans ± standard error.
| Week | P -values | |||||||
|---|---|---|---|---|---|---|---|---|
| 0 | 2 | 4 | 10 | 16 | Treatment | Week | Treatment * week | |
| Prostaglandin E2 (pg/mL) | ||||||||
| CAM | 0.88 ± 1.45 | 2.77 ± 1.45 | 3.49 ± 1.45 | 2.35 ± 1.45 | 2.32 ± 2.33 | |||
| OLA | 3.07 ± 1.34 | 3.07 ± 1.38 | 2.41 ± 1.44 | 2.82 ± 1.44 | 2.80 ± 1.39 | 0.9734 | 0.3965 | 0.9868 |
| FLX | 2.55 ± 1.23 | 4.07 ± 1.28 | 3.07 ± 1.34 | 3.44 ± 1.28 | 3.15 ± 1.33 | |||
| Junction plakoglobin (ng/mL) | ||||||||
| CAM | 8.73 ± 1.08 | 9.38 ± 1.08 | 8.56 ± 1.11 | 8.65 ± 1.08 | 7.82 ± 1.08 | |||
| OLA | 10.09 ± 1.01 | 9.60 ± 1.01 | 9.51 ± 1.01 | 9.96 ± 1.01 | 7.39 ± 1.09 | 0.9693 | 0.2487 | 0.9133 |
| FLX | 8.94 ± 0.94 | 10.97 ± 0.94 | 10.78 ± 0.94 | 9.34 ± 0.97 | 8.35 ± 1.02 | |||
| Glycosaminoglycan (μg/mL) | ||||||||
| CAM | 4.43 ± 0.73 | 4.73 ± 0.73 | 4.23 ± 0.73 | 4.91 ± 0.80 | 3.97 ± 0.76 | |||
| OLA | 3.03 ± 0.73 | 4.34 ± 0.73 | 4.47 ± 0.72 | 4.17 ± 0.76 | 3.74 ± 0.72 | 0.2083 | 0.9945 | 0.9147 |
| FLX | 4.33 ± 0.66 | 4.50 ± 0.66 | 4.82 ± 0.69 | 4.85 ± 0.69 | 4.04 ± 0.78 | |||
| Nitric oxide (μM/mL) | ||||||||
| CAM | 2.20 ± 5.50 | 9.30 ± 5.50 | 4.82 ± 5.62 | 8.34 ± 5.60 | 10.90 ± 5.64 | |||
| OLA | 4.31 ± 5.05 | 7.19 ± 5.05 | 5.85 ± 5.05 | 9.26 ± 5.05 | 10.15 ± 5.18 | 0.6476 | 0.3587 | 0.7288 |
| FLX | 11.70 ± 4.58 | 12.76 ± 4.58 | 19.56 ± 4.72 | 13.74 ± 4.72 | 16.34 ± 4.72 | |||
aTreatment oils: CAM, Camelina; OLA, Canola; FLX, Flaxseed oil; Data presented as mean ± standard error; n for each treatment group on weeks 0, 2, 4: CAM = 10, OLA = 10, FLX = 10, and weeks 10, 16: CAM = 10, OLA = 10, FLX = 9.